Harvard Bioscience (HBIO) Return on Capital Employed Growth (3y) (2014 - 2026)
Harvard Bioscience (HBIO) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 424.00 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 20.00 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 721.00 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -368.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 5.00 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -200.00 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2,491.00 |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | 6,090.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,090.00 |
| Dec 31, 2025 | -1,939.00 |
| Sep 30, 2025 | -18,506.00 |
| Jun 30, 2025 | -19,601.00 |
| Mar 31, 2025 | -10,135.00 |
| Dec 31, 2024 | -487.00 |
| Sep 30, 2024 | -885.00 |
| Jun 30, 2024 | -763.00 |
| Mar 31, 2024 | -530.00 |
| Dec 31, 2023 | 68.00 |
| Sep 30, 2023 | 596.00 |
| Jun 30, 2023 | 462.00 |
| Mar 31, 2023 | 737.00 |
| Dec 31, 2022 | -184.00 |
| Sep 30, 2022 | -402.00 |
| Jun 30, 2022 | -220.00 |
| Mar 31, 2022 | -477.00 |
| Dec 31, 2021 | 86.00 |
| Sep 30, 2021 | 131.00 |
| Jun 30, 2021 | 192.00 |